M Capital, Normandie Participations lead €4.7m Robocath round

They were joined in the round by previous investors in the company Go Capital and NCI Gestion.

The funds will be used to continue development of robotic technology to manage endovascular procedures for the treatment of cardiovascular diseases.

Previous funding
Go Capital and NCI led a €900,000 seed funding round for Robocath in May 2013, with the aim of strengthening the research and development team. Both VCs reinvested the same amount in July 2015, with €300,000 coming from NCI's Croissance et Proximité 2 fund and Go Capital making up the other €600,000.

Company
Established in 2009 and based in Rouen, Robocath is developing robots for remote arteriography. It also offers its solutions for use by cardiologists, interventional radiologists, urologists and other surgeons. It is currently at the manufacturing stage for the robotic platform R-One. It is hoped the technology will improve patient care and reduce physicians' exposure to x-rays. The company employs a staff of 20.

People
Robocath – Philippe Bencteux (chairman).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Early-stage
• France
• Healthcare
• France
• Venture
• NCI Gestion